genedrive plc (LON:GDR – Get Free Report)’s share price rose 17.2% during mid-day trading on Tuesday . The company traded as high as GBX 1.17 and last traded at GBX 1.06. Approximately 7,344,195 shares traded hands during trading, a decline of 63% from the average daily volume of 19,787,230 shares. The stock had previously closed at GBX 0.90.
genedrive Trading Up 14.4%
The firm’s 50-day simple moving average is GBX 0.70 and its 200 day simple moving average is GBX 0.94. The stock has a market cap of £10.60 million, a P/E ratio of -0.48 and a beta of -0.04. The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Featured Stories
- Five stocks we like better than genedrive
- Should You Invest in Penny Stocks?
- Carvana Soars Over 10,000% From Lows—Now It’s in the S&P 500
- What Are Dividend Champions? How to Invest in the Champions
- UiPath Surges on Earnings: Should Investors Chase the Momentum?
- What Are Treasury Bonds?
- Pure Storage’s 27% Fall: Real Opportunity or Deserved Correction?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
